❌

Reading view

↗️

ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway

βœ‡Cell Death Discovery nature.com science feeds
By: Xiaoting Chen Β· Xujie Zhou Β· Yuting Sang Β· Zehao Wang Β· Yue Zhou Β· Zhishuang Gao Β· Yanhui Wang Β· Yangsiyuan Zhao Β· Rui Xu Β· Bingqiu Xiu Β· Jingyan Xue Β· Jiong Wu

Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03349-8

ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway
  •  
  • ↗️
↗️

Hepatic Usp2 orchestrates de novo lipogenesis through G3bp2 stabilization and Ξ²-catenin activation

βœ‡Cell Death Discovery nature.com science feeds
By: Wei Wang Β· Hui Wang Β· Yihan Liu Β· Siyuan Cui Β· Chuanxi Tang Β· Mengxue Wang Β· Chunyan Mu Β· Jingyu Li Β· Xianlong Ye Β· Xinmiao Liang Β· Shenglong Zhu

Cell Death Discovery, Published online: 14 September 2026; doi:10.1038/s41420-026-03333-2

Hepatic Usp2 orchestrates de novo lipogenesis through G3bp2 stabilization and Ξ²-catenin activation
  •  
  • ↗️
There are no more articles
❌